1. RM Kirby, JA Young, SG Hubcher, GB Cuthberton, AB Jain, P McMaster. Cytological diagnosis of hepatic dysfunction following liver transplantation. Abstract: Gut 27:A1265, 1986.

  2. AB Jain, N Jabbour, H Ramos, JJ Fung, TE Starzl, DH Van Thiel. Incidence and severity of liver allograft rejection following institution of Alpha Interferon for treatment of viral hepatitis in liver transplant recipients. 94th annual meeting The American Gastroenterological Association. Boston, MA. Abstract: Gastroenterology, 104(4)2; A922, May1993.

  3. JJ Fung, AB Jain, I Hamad, H Doyle, R Selby, A Tzakis, S. Todo, TE Starzl. Long-term effects of FK 506 following conversion from Cyclosporine to FK 506 for chronic rejection in liver transplant recipients. American Association for the Study of Liver Disease. Chicago, IL. Abstract : Hepatology 18: (4)2– 1(A); 74, November 1993.

  4. AB Jain, A Tsamandas, AJ Demetris, W Irish, H Ramos, N Jabbour, L Echeverri, DH Van Thiel, TE Starzl, JJ Fung. Interferon Alpha 2B for Non A, Non B, and Non C hepatitis in liver allograft recipients. Clinical and Pathological Outcome. American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4)2:13A, October 1994.

  5. AB Jain, JJ Fung, S Todo, H Ramos, R Selby, W Irish, J Reyes, N Jabbour, R Venkataramanan, TE Starzl. Adult Primary Orthotopic Liver Transplantation under FK 506: four-year follow up. American Association for the Study of Liver Diseases. November 11-15, 1994. Chicago, IL. Abstract: Hepatology 20(4)2:137A, October 1994.

  6. AB Jain, A Tsamandas, AJ Demetris, W Irish, R Manez, H Ramos, N Jabbour, L Echeverri, DH Van Thiel, TE Starzl, JJ Fung. Clinical outcome and pathological correlation following interferon Alpha 2B treatment of recurrent hepatitis B and hepatitis C in orthotopic liver allograft recipients. American Association for the Study of Liver Diseases. November 11-15, 1994. Chicago, IL. Abstract: Hepatology 20(4)Pt 2:130A, October 1994.

  7. Reyes, AB Jain, S Todo, M Green, JJ Fung, N Jabbour, TE Starzl. Pediatric primary orthotopic liver transplantation under tacrolimus. The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27-30, 1995. London, United Kingdom. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

  8. J Reyes, AB Jain, S Todo, JJ Fung, M Green, N Jabbour, TE Starzl. Conversion from Cyclosporine to tacrolimus in pediatric liver transplant recipients. The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27-30, 1995. London, United Kingdom. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

  9. AB Jain, JJ Fung, I Hamad, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, AJ Demetris, TE Starzl. Long-term outcome of conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: Actual more than five years’ follow up. The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27-30, 1995. London, United Kingdom. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

  10. AB Jain, JJ Fung, I Hamad, S Todo, J Reyes, N Jabbour, D Kramer, A Casavilla, J Rakela, JW Marsh, S Iwatsuki, TE Starzl. Adult primary liver transplantation under tacrolimus: More than five years’ actual follow up. The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27-30, 1995. London, United Kingdom. Abstract: Liver Transplantation Surgery 1(6)425, November 1995.

  11. AF DiMartini, AB Jain, JJ Fung, W Irish, J Magill, J Rakela, TE Starzl. Liver transplantation in alcoholic and non-alcoholic cirrhosis: Survival according to UNOS status, sobriety and rehabilitation. The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27-30, 1995. London, United Kingdom. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

  12. AB Jain, R Venkataramanan, JJ Fung, J Reyes, J Lever, VS Warty, S Todo, TE Starzl. Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients. The American Association for the Study of Liver Diseases. November 3-7, 1995. Chicago, IL. Abstract: Hepatology 22(4)2:143A, October, 1995.

  13. A Khanna, AB Jain, G Ziady, JJ Fung, R Jaffe, L Mieles, TE Starzl, J Reyes. Cardiac changes at autopsy in pediatric liver transplant recipients under tracolimus. The 2nd International Congress on Pediatric Transplantation. August 22-24, 1996. Paris, France. Abstract: Pediatric Nephrology 10:C-31-C94, 1994.

  14. AB Jain, J Reyes, L Mieles, JJ Fung, S Todo, J McMichaels, TE Starzl. Conversion of pediatric liver allograft recipients from Cyclosporine to tacrolimus-based immunosuppression. The 2nd International Congress on Pediatric Transplantation. August 22-24, 1996. Paris, France. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

  15. J Reyes, J Fricker, L Mieles, E Jovine, AB Jain, S Todo, JJ Fung, H Noyola, TE Starzl. Reversible myocardial hypertrophy after liver and liver/small bowel transplantation in children under tacrolimus (FK 506) immunosuppression. The 2nd International Congress on Pediatric Transplantation. August 22-24, 1996. Paris, France. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

  16. AB Jain, L Mieles, S Todo, JJ Fung, J McMichael, TE Starzl, J Reyes. Primary liver transplantation in children under tacrolimus. The 2nd International Congress on Pediatric Transplantation. August 22-24, 1996. Paris, France. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

  17. A Khanna, AB Jain, L Mieles, JJ Fung, S Todo, TE Starzl, J Reyes. Liver retransplantation in children: study of 184 cases. The 2nd International Congress on Pediatric Transplantation. August 22-24, 1996. Paris, France. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

  18. AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, S Iwatsuki, TE Starzl. More than six years’ actual follow up: Primary adult liver transplantation under tacrolimus. The American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.

  19. AB Jain, M Gadomski, JJ Fung. Conversion from Cyclosporine to Neoral in stable liver transplant recipients. The American Association for the Study of Liver Disease, 1996. Hepatology 24(4):181A, 1996.

  20. AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, S Iwatsuki, TE Starzl.. More than 6 years actual follow-up: Primary adult liver transplantation under tacrolimus. The American Association for the Study of Liver Disease, 1996. Abstract: Hepatology 24(4):181A, 1996.

  21. AB Jain, JJ Fung, S Todo, J Rakela, AJ Demetris, S Iwatsuki, TE Starzl. More than six years actual follow-up conversion from cyclosporine to tacrolimus for chronic liver allograft rejection. The American Association for the Study of Liver Disease, 1996. Abstract: Hepatology 24(4):181A, 1996.

  22. E Molmenti, J Beuno, R Venkataramanan, JJ Fung, AB Jain, S Todo, J Reyes. Use of mycophenolate mofetil in the pediatric population after liver and intestinal transplantation. Fourth Congress International Liver Transplantation Society. Seattle, WA. October 15-17. Abstract: Liver Transplantation and Surgery 3(5); C-78(189), 1977.

  23. E Molmenti, J Beuno, T Cacciarelli, B Kosmach, AB Jain, JJ Fung, J Reyes. Adolescent noncompliance following liver transplantation. Fourth Congress International Liver Transplantation Society. Seattle, WA. October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5); C-77 (188), 1997.

  24. AB Jain, JJ Fung, I Hamad, J Rakela, J Demetris, J McMichael. Prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and mycophenolate mofetil in primary adult liver transplant recipients. Fourth Congress International Liver Transplantation Society Plenary Session. Seattle, WA. October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5); C-55 (70), 1997.

  25. AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, J Rakela, TE Starzl. More than seven years’ actual follow-up: Primary adult liver transplantation under tacrolimus. Fourth Congress International Liver Transplantation Society. Seattle, WA. October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5); C-71(162), 1977.

  26. AB Jain, A Singhal, JJ Fung, R Lee, AC Tsamandas,TE Starzl, J Demetris. Chronic rejection following primary adult liver transplantation under tacrolimus. American Association for the Study of Liver Diseases. Chicago, Illinois. November 7-11, 1997. Abstract: Hepatology 29 (4);2,343 A, 1997. Abstract #859.

  27. AB Jain, R Kashyap, B Carr, J Rakela, JJ Fung. Clinical significance of elevated serum α-feto protein among patients with end-stage liver disease. American Association for the Study of Liver Diseases. Chicago, IL. November 7-11, 1997. Abstract: Hepatology 29 (4)2;171A, 1997. Abstract #171.

  28. AB Jain, JJ Fung, I Hamad, S Zuckerman. Use of mycophenolate mofetil for tacrolimus related chronic nephrotoxicity in liver transplantation recipients. American Association for the Study of Liver Diseases. Chicago, Illinois. November 7-11, 1997. Abstract: Hepatology 29 (4)2; 235A,1997. Abstract #427.

  29. A Jain, JJ Fung, I Hamad, F Dodson, J Rakela, D Kramer, J McMicheal, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and steroids versus tacrolimus steroids and Mycophenolate Mofetil. American Society of Transplant Surgeons 24th Annual Meeting. Chicago, IL. May 13-15, 1998. Abstract: Transplantation 66(6); S2(6) 1998.

  30. A Jain, JJ Fung, J Reyes, R Kashyap, S Rohal, J Rakela, T. Cacclarelli, TE Starzl. Primary liver transplantation under tacrolimus in infants, children, adults and seniors: 1000 consecutive patients from single center with five-to-eight years’ actual follow-up. Abstract: Transplantation 66(6); S43(172), 1998.

  31. J. Reyes, AB Jain, G. Mazariegos, R. Kashyap, J. Fung. Conversion of pediatric liver allograft recipients from Cyclosporine in tacrolimus-based immunosuppression four-to-eight years’ follow up. The International Congress on Pediatric Transplantation, 1998. Abstract: Pediatric Transplantation (2)75, 1998. Abstract #177.

  32. E. Molmenti, J. Bueno, T. Cacciarelli, B. Kosmach, J. DeBlass, AB Jain, JJ. Fung, G. Mazariegos, J. Reyes. Noncompliance after pediatric liver transplantation. 2(1)78, 1998. Pediatric Transplantation 2(78) 1998. Abstract #192.

  33. AB Jain, I Hamad, R. Kashyap, SN. Rishi, D. Kramer, J. Rakela, JJ. Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary adult liver transplantation. American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 221A, 1998. Abstract: 233.

  34. AB Jain, AK. Singhal, J. Reyes, J. Rakela, JJ Fung. Long-term impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus. American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 351A, 1998. Abstract #756.

  35. AB Jain, J. Reyes, R. Kashyap, N. Rishi, S. Rohal, J. Rakela, JJ. Fung. Primary liver transplant under tacrolimus in infants, children, adults and seniors: 1000 consecutive cases: mean follow up seven years. . American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 351A, 1998. Abstract: #755.

  36. J. Reyes, AB Jain, G. Mazariegos, NR. Kashyap, J. Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus-based immunosuppression: Mean seven years’ actual follow up. American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4) 2; 351A, 1998 Abstract #754.

  37. J. Reyes, AB Jain, G. Mazariegos, R. Kashyap, T. Cacciarelli, N. Rishi, J. Fung. Primary liver transplantation in children under tacrolimus and Cyclosporine: comparative study. American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 351A, 1998. Abstract #753.

  38. AB Jain, J. Demetris, J. Rakela, JJ. Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: more than eight years’ actual follow up. American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 221A, 1998. Abstract #233.

  39. AB Jain, A. DiMartini, N. Rishi, MG. Fitzgerald, S. Rohal, J. Rakela, J. Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. International Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, Illinois, November 4-10, 1998. Abstract: Hepatology 28(4)2;350A, 1998. Abstract #752.

  40. J. Rogers, AB Jain, M. DeVera, B. Yelochan, J. Rakela, J. Fung. Long-term outcome of hepatitis C viral infection in primary adult liver transplant recipients compared to non-HCV under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7) S15, 1999.

  41. C. Doria, AB Jain, I. Marino, S. Gruttadauria, V.L. Scott, J.J. Fung. Conversion from tacrolimus to Cyclosporine A following primary liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67(7);S32, 1999.

  42. G. Burckart, R. Frye, R. Branch, R. Venkataramanan, T. McKaveney, R. Hammond, C. Rosenberg, J. Fung, AB Jain. Drug metabolism in older OLTx patients: effects of donor and recipient age. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7) S145, 1999.

  43. AB Jain, J.J. Fung, S. Todo, J. Rakela, J. Demetris, S. Iwatsuki. T. E. Starzl. More than six years’ actual follow-up: Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999 Chicago, IL. Abstract: Transplantation 67(7) S197, 1999.

  44. AB Jain, A. DiMartini, N. Rishi, M.G. Fitzgeral, S. Rohal, J. Rakela, J. Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7); S765, 1999.

  45. AB Jain, A.K. Singhal, J. Reyes, J. Rakela, J.J. Fung. Long-term impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7); S198, 1999.

  46. J. McCauley, AB Jain, I Hamad. J. Fung. Acute renal failure requiring dialysis in liver transplant recipients under tacrolimus, Prednisone versus tacrolimus, Prednisone and Cellcept. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7); S201, 1999.

  47. M. Devera, AB Jain, A. Tsamandas, J. Rogers, J. Rakela, J. Fung. Long-term effect of Interferon-a for HCV infection in post-liver transplantation: actual seven-to-nine years’ follow up. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7); S201, 1999.

  48. AB Jain, G. Mazariegos, K. Iulano, J. Fung, J. Reyes. Why some children are still on steroid beyond five years’ post-liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7); S231, 1999.

  49. A.B. Jain, J. Reyes, G. Mazariegos, T. Cacciarelli, R. Kashyap, M. Nalesnik, S. Rohal, J.J. Fung. Incidence of post-transplant lymphoproliferative disorder in adults and children: consecutive 1000 primary liver transplant recipients under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), Chicago, IL, May 15-19, 1999. Abstract: Transplantation 67 (7) S246, 1999.

  50. AB Jain, K. Blakomer, J.J. Fung. Post-transplant lymphoproliferative disorder (PTLD) following adult liver transplantation: Retrospective study of over 4000 patients over 15 years from single center. 25th Annual Scientific Meeting, the American Society of Transplant Surgeons, Chicago, IL, May 19-21, 1999. Abstract: Transplantation 67 (9); S587, 1999.

  51. JR Madariaga, AB Jain, G. Costa, J. Reyes, G. Mazariegos, S.F. Dodson. J. Rakela, J. J. Fung. Hepatic artery complications following primary liver transplantation in adults and children: 1000 consecutive cases under tacrolimus. 25th Annual Scientific Meeting, the American Society of Transplant Surgeons, Chicago, IL, May 19-21, 1999. Abstract: Transplantation 67 (9); S599, 1999.

  52. AB Jain, S. Rohal, J. Madariaga, K. Abu-Elmagd, F. Dodson, J. Rakela, J.J. Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. 25th Annual Scientific Meeting, the American Society of Transplant Surgeons, Chicago, IL, May 19-21, 1999. Abstract: Transplantation 67 (9); S601, 1999

  53. AB Jain, J. Mazrariegos, K. Iurlano, J. Fung, J. Reyes. Under tacrolimus, why some children are still on steroids beyond five years’ post-liver transplantation? Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4): C-3, 12A, July 1999.

  54. AB Jain, S. Rohal, J. Madariaga, K. Abu-Elmagd, F. Dodson, J. Rakela, J. Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4); p. C-4, 12B, July 1999.

  55. AB Jain, J. Fung, I. Hamad, S. Zuckerman, D. Venkataramanan. Use of Mycophenolate Mofetil for tacrolimus-related chronic nephrotoxicity in liver transplant recipients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4); p. C-4, 13, July 1999.

  56. AB Jain, J. Reyes, G. Mazariegos, T. Cacciarelli, R. Kashyap, M. Nalesnik, S. Rohal, J. Fung. Post-transplant lymphnoproliferative disorder in adults and children: consecutive 1000 primary liver transplant recipients under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4); p. C-7, 27A, July 1999.

  57. AB Jain, K. Blakomer, J. Fung, P. Randhawa, F. Dodson, J. Rakela, M. Nalesnik. Incidence of post-transplant lymphoproliferative disorder (PTLD): retrospective study of over 4000 adults after liver transplantation 15 years’ experience from a single center. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4); p. C-8, 27B, July 1999.

  58. AB Jain, I. Hamad, F. Dodson, D. Kramer, J. Rakela, A. Demetris, J. Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus and Mycophenolate Mofetil in primary adult liver transplantation. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4); p. C-25, 97, July 1999.

  59. AB Jain, H. Imad, M. Funovits, J. Fung. Detection of early antigenemia (pp65) in peripheral blood leukocytes and pre-emptive therapy for cytomegalovirus infection in liver transplant recipients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4); p. C-35, 135, July 1999.

  60. J. Reyes, AB Jain, G. Mazariegos, N. Kashyap, J. Fung. Conversion of pedriatric liver liver allograft recipients from Cyclosporin to Tacrolimus for acute and chronic rejection: mean seven years follow-up. Fifth Congress of the International Liver Transplantation Society, August 26-28, 1999, Pittsburgh. Abstract: Liver Transplantation and Surgery 5(4) p. C-38, 147, July 1999.

  61. J. Reyes, AB Jain, G. Mazariegos, R. Kashyap, T. Cacciarelli, N. Rishi, J. Fung. Comparative study: Primary liver transplantation in children under tacrolimus and Cyclosporine. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-38, 148, July 1999.

  62. AB Jain, A. Singhal, J. Reyes, J. Rakela, J. Fung. Impact of positive crossmatch due to IgC versus IgM antibodies in primary liver transplantation under tacrolimus in long term. Fifth Congress of the International Liver Transplantation Society, Pittsburgh,PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-26, 99, July 1999.

  63. G. Burckart, R. Frye, R. Branch, R. Venkataramanan, T. Mckaveney, R, Hammond, C. Rosenberg, J. Fung, AB Jain. Drug metabolism in older OLTx patients: Effects of donor and recipient age. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-27, 104, July 1999.

  64. AB Jain, J. Reyes, R. Kashyap, N. Rishi, S. Rohal, J. Rakela, J. Fung. Primary liver transplant under tacrolimus in infants, children, adults and seniors: 1000 consecutive cases: Mean follow up seven years. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-27, 103, July 1999.

  65. AB Jain, J. McCauley, R. Kashyap, A. Rafail, J. Fung. End-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: Adults and children. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-27, 105, July 1999.

  66. C. Doria, AB Jain, I. Marino, S. Gruttadauria, V. Scott, J. Fung. Conversion from tacrolimus to Cyclosporine A following primary liver transplantation under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, August 26-28, 1999. Abstract: Liver Transplantation and Surgery (5)4 p. C-28, 106, July 1999.

  67. S. Agarwal. E. Culligan, AB Jain, P. Chakraborti, G. Matzke, J. McCauley, R. Shapiro, G. Burckart, M. Virji, R. Venkataramanan. Assesment of renal fuction in liver and renal transplant patients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-28, 107, July 1999.

  68. J. Pisupati, AB Jain, S. Zuckerman, I. Hamad, J. Lever, R. Venkatarmanan. Time dependent changes in the kinetics of mycophenolate acid (MPA) in liver transplant patients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-30, 114, July 1999.

  69. R. Venkataramanan, AB Jain, I. Hamad, S. Mehta, V. Warty, J. Fung. Mycophenolate Mofetil has no effect on tacrolimus pharmacokinetics in liver transplant patients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-30, 116, July 1999.

  70. J. Rogers, AB Jain, M. DeVera, B. Yelochan, J. Rakela, J. Fung. Outcome of Hepatitis C Viral (HCV) infection in primary adult liver transplant recipients compared to non-HCV under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-33, 128, July 1999.

  71. M. DeVera, AB Jain, A. Tsamandas, J. Rakela, J. Fung. Results of Interferon-a for HCV infection post-liver transplantation: results after actual five-to-seven years’ follow up. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-33, 129, July 1999.

  72. AB Jain, J. Fung, J. Reyes, R. Venkatarmanan. Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pedriatric and adult liver transplant recipients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-39, 150, July 1999.

  73. AB Jain, J. Madriaga, G. Costa, J. Reyes, G. Mazriegos, F. Dodson, J. Rakela, J. Fung. Rate of hepatic artery complication following primary liver transplantation in adults and children: 1000 consecutive cases under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-42, 162, July 1999.

  74. J. McCauley, AB Jain, I. Hamad, J. Fung. Post-operative acute renal failure in liver transplant recipients under tacrolimus, Prednisone versus tacrolimus, Prednisone and Cellcept. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-42, 163, July 1999.

  75. AB Jain, J. Demetris, J. Rakela, T. Starzl, J. Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than six years’ actual follow up. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-49, 191, July 1999.

  76. A. Dimartini, N. Day, M. Dew, T. Lane, AB Jain. Outcome of liver transplantation in alcoholic cirrhosis. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-51, 198, July 1999.

  77. R. Kashyap, AB Jain, B. Carr, J. Rakela, Barnes, J. Fung. Elevated serum a-feto protein among patients with end-stage liver disease and its clinical significance. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-57, 222, July 1999.

  78. R. Venkatarmanan. J. Ou, S. Zuckerman, J. Pisupati, AB Jain. Does plasma protein binding of Mycophenolate acid affect its clearance? Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4), p. C-59, 231, July 1999.

  79. AB Jain, I. Hamad, S. Zuckerman, J. Pisupati, R. Venkatarmanan, T. Starzl. The pharmacokinetics of oral tacrolimus in liver transplant patients: Study of intra-individual variation. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery 5(4) p. C-59, 232, July 1999.

  80. AB Jain, K. Blakolmer, R. Kashyap, K. Rupper, S. Rohal, T.E. Starzl, JJ Fung, J. Demetris. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (ltx)?: analysis of 6057 biopsies in 1055 LTx mean follow up six years. 50th American Association for the Study of Liver Diseases, Dallas, TE, November 5-8, 1999. Abstract: Hepatology 30(4)2. Abstract #601.

  81. AB Jain, JJ Fung, R. Kashyap, S. Rohal, M. Nalesnik. Comparative study of post-transplant lymphoproliferative disorder and de novo cancer after liver transplantation under tacrolimus. 50th American Association for the Study of Liver Diseases, Dallas, Texas, November 5-8, 1999. Abstract: Hepatology 30(4)2; 173. Abstract #50.

  82. AB Jain, K. Blakolmer, P. Randhawa, R. Kashyap, JJ Fung, M. Nalesnik. Rate of post-transplant lymphoproliferative disorder (PTLD) under Cyclosprine and tacrolimus-based immunosuppression: review of 4022 adult liver transplant patients. 50th American Association for the Study of Liver Diseases, Dallas, Texas, November 5-8, 1999. Abstract: Hepatology 3(4) 2. Abstract #602.

  83. J. Rogers, AB Jain, M. De Vera, J. Rakela, JJFung. Under tacrolimus outcome of Hepatitis C viral (HCV) infection in primary adult liver transplant recipients compared to non-HCV: Mean follow up of 93 months. 50th American Association for the Study of Liver Diseases, Dallas, Texas, November 5-8, 1999. Abstract: Hepatology 30(4)2; 179A. Astract #74.

  84. A. N. Vats, R. Shapiro, D. Ellis, A. Gautam, P. S. Randhawa, M. Saxena, V. Scantlebury, C. Vivas, M. Jordan, AB. Jain, R, Tadikamalla, K. Weck. Developoment of quantitative PCR for BK Virus detection in urine and its role in management of allograft viral infection masquerading as acute rejection. Transplant 2000, Chicago, IL, May 13-17, 2000. Abstract: Transplantation 69(8), S136. Abstract #96.

  85. P. Chakrabarti, H. Wong, A. Toyofuku, V. Scantlebury, M. Jordan. C. Vivas, AB. Jain, J. McCauley, J. Johnston, P. Randhawa, T, Hakala, R. Simmons, J. Fung, TE Starzl. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant 2000, Chicago, IL, May 13-17, 2000. Abstract: Transplantation 69(8) S 224. Abstract #425.

  86. AB. Jain, J. Reyes, G. Mazariegos, R. Kashyap, R. Jaffe, J. Fung, M. Nalesnik. Rate of post-transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus, 766 consecutive recipients: 15 years’ experience. Transplant 2000, Chicago, IL, May 13-17, 2000. Abstract: Transplantation 69(8)317. Abstract #787.

  87. R. Kashyap, AB. Jain, J. Reyes, A.J. Demetris, J. Fung. Cause of re-transplantation, rate and survival after 4000 consecutive primary liver transplantations from a single center with 15 years’ median follow up. Transplant 2000, Chicago, IL, May 13-17, 2000. Abstract: Transplantation 69(8) S 320. Abstract #800.

  88. R. Shapiro, P. Randhawa, M. Jordan, V. Scantlebury, C. Vivas, AB. Jain, R. J. Corry, J. McCauley, J. Johnston, J. Donaldson, E. Gray, I. Dvorchik, T. Hakala, J. Fung, T. Starzl. An analysis of early renal transplantation protocol biopsies–the high incidence of sub-clinical acute rejection. Transplant 2000, Chicago, IL, May 13-17, 2000. Abstract: Transplantation 69(8) S365. Abstract #972.

  89. AB. Jain, A.J. Demetris, R. Kashyap, T.E. Starzl, J. J. Fung. Survival patterns after liver transplantation: Effect of age, gender, and era in 4000 consecutive patients from a single center with 15 years’ median follow up. American Surgical Association 120th Annual Meeting, Philadelphia, PA, April 6-8, 2000.

  90. G. Costa, AB. Jain, J. Madariaga, J. Reyes, G. Mazariegos, R. Kashyap, J.J. Fung. Bile duct complications following liver transplantation in adults and children: 1000 consecutive patients. International Liver Transplantation Society Sixth Congress, Buenos Aires, Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #57.

  91. M. Giraldo, AB. Jain, D. Martini, F. Dodson, J. Fung. Outcome of liver transplantation for hemophiliacs and HCV, with or without HBV and HIV infection under tacrolimus. Nine years’ experience from a single center. International Liver Transplantation Society Sixth Congress, Buenos Aires , Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #94.

  92. AB. Jain, K. Blakomer, R. Kashyap, K. Ruppert, S. Rohal, T.E. Starzl, J. Fung, J. Demetris. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx): Review of 5252 biopsies in 1055 LTx, mean follow up—six years. Sixth ILTS Congress, Buenos Aires , Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #105.

  93. AB. Jain, R. Kashyap, J. Reyes, A.J. Demetris, J. Fung. Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Median follow up 15 years. International Liver Transplantation Society Sixth Congress, Buenos Aires, Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #110.

  94. R. Kashyap, AB. Jain, J. Reyes, A. J, Demetris, J. Fung. Causes of re-transplantation after 4000 consecutive primary liver transplantations from a single center with 15 years’ median follow up rate and survival. International Liver Transplantation Society Sixth Congress, Buenos Aires , Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #112.

  95. AB. Jain, J. Fung, R. Kashyap, S. Rohal, M. Nalesnik. Incidence of de novo cancer and post-transplant lymphoproliferative disorder after liver transplantation under tacrolimus comparative study. International Liver Transplantation Society Sixth Congress, Buenos Aires, Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #129.

  96. AB Jain, J. Reyes, G. Mazariegos, R. R. Kashyap, R. Jaffe, M. Green, J. Fung, M. Nalesnik. Under Cyclosporine and tacrolimus’ rate of post-transplant lymphoproliferative disorders (PTLD) in children: 766 consecutive recipients of 15 years’ experience. International Liver Transplantation Society Sixth Congress, Buenos Aires, Argentina, June 21-23, 2000. Abstract: Liver Transplantation 6(3). Abstract #131.

  97. A.B. Jain, R. Kashyap, F. Dodson, D. Kramer, J.J. Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary liver transplant: A complete report. XVII International Congress of the Transplantation Society, Rome, Italy, August 27 – September 1, 2000. Abstract: Pediatric Transplantation 4(2);150, 2000.

  98. A.B. Jain, G. Mazariegos, R. Kashyap, et al. Pediatric liver transplantation in 808 consecutive children: 18 years’ experience from a single center. First Congress of the International Pediatric Transplant Association, Venice, Italy, August 23-25, 2000. Abstract: Pediatric Transplantation 4(2)73; 2000.

  99. AB Jain, G Mazariegos, R Kashyap, JJ Fung, TE Starzl, J Reyes. Absence of chronic rejection under tacrolimus in pediatric liver transplant recipients: Mean follow up of nine years. Accepted as poster at the Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-47; 2001. Abstract #185.

  100. AB Jain, G Mazariegos, R Kashyap, K Iurlano, JJ Fung, J Reyes. Pediatric Liver Transplantation in 808 consecutive children: 18-years’ experience from a single center. Accepted as poster at the Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-78; 2001. Abstract #312.

  101. Y Daly, AB Jain, R Kashyap, JJ Fung, J Reyes. Use of Mycophenolate Mofetil (MMF) for chronic rejection in liver allograft under tacrolimus. Accepted as oral presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-83; 2001. Abstract #330.

  102. R Kashyap, AB Jain, A Demetris, S Kusne, J Fridell, E Asham, JJ Fung. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post-liver transplant allograft under tacrolimus. Accepted as oral presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-14; 2001. Abstract #54.

  103. AB Jain, R Kashyap, B Eghtesad, G Costa, JJ Fung. The question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. Accepted as a poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-51; 2001. Abstract #228.

  104. AB Jain, R Kashyap, B Eghtesad, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Accepted as a poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-5; 2001. Abstract #19.

  105. AB Jain, R Kashyap, B Eghtesad, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Accepted as a poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-33; 2001. Abstract #130.

  106. A.B. Jain, G. Mazariegos, Randeep S. Kashyap, John J. Fung, Thomas E. Starzl, Jorge Reyes. Tacrolimus offers total absence of chronic rejection in pediatric liver transplant recipient: Follow up of 7-10 years. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, 2001, p. 246A. Abstract #292.

  107. A.B. Jain, Randeep S. Kashyap, K. Abu-Elmagd, P. A. Fontes, J.J. Fung, M. Nalesnik. Use of Rituximab (chimeric anti CD20 antibody) in post transplant lymphoproliferative disorder (PTLD) after liver transplantation. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, p. 285A, 2001. Abstract #452.

  108. R.S. Kashyap, A.B. Jain, J.J. Fung. Impact of cytomegaloviral (CMV) hepatitis in adult post liver transplant allograft under tacrolimus. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, p. 285A, 2001. Abstract #453.

  109. AB Jain, R.S. Kashyap, B. Eghtesad, S. Obaid, V. Ramesh, K. Akhtar, J.J. Fung. Ribavirin Dose Adjustment in relation to renal function is mandatory for treatment of recurrent HCV infection in post liver transplant patients. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2 p. 409A, 2001. Abstract #947.

  110. ME deVera, B Eghtesad, AB Jain, SF Dodson, JJ Fung, CA Bonham. Liver Transplantation in Patients Co-Infected with HIV and Hepatitis C. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transpl 2;(Suppl 3):139, Abstract #5.

  111. B Eghtesad, SF Dodson, AB Jain, O Shakil, CA Bonham, PA Fontes, TV Cacciarelli, DA Geller, JW Marsh, R Pokharna, JJ Fung. Prevention of Recurrent Hepatitis B Virus after Liver Transplantation with Restricted Elimination of Hepatitis B Immune Globulin. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transpl 2;(Suppl 3):140, Abstract #11.

  112. AB Jain, R. Venkataramanan, R Shapiro, VP Scantlebury, S Potdar, CA Bonham, M Ragni, JJ Fung. The Interaction between Anti-Retroviral Agents and Tacrolimus in Liver and Kidney Transplant Patients. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transpl 2:(Suppl 3):234, Abstract #385.

  113. JA Fridell, AB Jain, R Biederman, JD Reyes, R Sindhi, GV Mazariegos. Causes of Mortality Beyond One Year Following Pediatric Liver Transplant Under Tacrolimus. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transpl 2(Suppl 3):295, Abstract #625.

  114. AB Jain, R Pokharna, GV Mazariegos, M Parizhskaya, R Jaffe, JJ Fung, JD Reyes. Tacrolimus Offers Almost Total Absence of Chronic Rejection in Pediatric Liver Transplant Recipients: Follow Up of 7-10 Years. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transpl 2:(Suppl 3):352, Abstract #853.

  115. TV Cacciarelli, AB Jain, JJ Fung, MA Nalesnik. The Impact of EBV-Negative Post-Transplant Lymphoproliferative Disorder on Survival in Adult and Pediatric Solid Organ Transplant Recipients. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transpl 2;(Suppl 3):427, Abstract #1147.

  116. AB Jain, R. Venkataramanan, B Eghtesad, R Shapiro, VP Scantlebury, S Potdar, CA Bonham, M Ragni, JJ Fung. The Interaction Between Anti-Retroviral Agents and Tacrolimus in Liver and Kidney Transplant in HIV+ Patients. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6):C-6, Abstract #24.

  117. JA Fridell, AB Jain, A Khan, E Asham, A Basu, JJ Fung, R Venkataramanan. Effect of T-Tube Clamping on Absorption of Rapamycin in Liver Transplantation Recipients. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6):C-6, Abstract #25.

  118. AB Jain, R. Venkataramanan, JA Fridell, B Eghtesad, MV Ragni, JJ Fung. Nelfinavir, A Protease Inhibitor, Increases Sirolimus Levels in Liver Transplant Patients: A Case Report. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6):C-10, Abstract #37.

  119. B Eghtesad, I Daly, B Broznck, DA Geller, PA Fontes, TV Cacciarelli, AB Jain, CA Bonham, SF Dodson, WJ Marsh, JJ Fung. Utilization of Livers from Non-Heartbeating Donors (NHBD): A Single Center Experience. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C17, Abstract #66.

  120. B Eghtesad, SF Dodson, AB Jain, O Shakil, CA Bonham, PA Fontes, TV Cacciarelli, DA Geller, JW Marsh, JJ Fung. Prevention of Recurrent Hepatitis B Virus After Liver Transplantation with Restricted Elimination of Hepatitis B Immune Globulin. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-35, Abstract #138.

  121. AB Jain, R Pokharna, K Abu-Elmagd, B Eghtesad, PA Fontes, M Gadomski, JJ Fung. Use of Rituximab (Chimeric Anti-CD20 Antibody) in Post-Transplant Lymphoproliverative Disorder (PTLD) After Liver Transplantation. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6):C-42, Abstract #168.

  122. JA Fridell, AB Jain, JA Reyes, R Biederman, R Sindhi, GV Mazariegos. Mortality Beyond One Year following Liver Transplant Under Tacrolimus Immunosuppression in Pediatric Patients. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6):C-68, Abstract #272.

  123. Corry R, Potdar S, Shapiro R, Scantlebury V, Randhawa P, AB Jain, McCauley J, Good D, Basu A, Fung JJ, Starzl TE. Pancreas and kidney-pancreas transplantation under a tolerogenic regimen of preconditioning with thymoglobulin and post-transplant tacrolimus. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #85.

  124. AB Jain, Venkataramanan R, Shapiro R, Scantlebury V, Eghtesad B, Potdar S, Ragni M, Fung JJ. Profound interaction between tacrolimus, rapamycin and anti-HIV drugs in liver and kidney transplant patients. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #172.

  125. Fridell JA, AB Jain, Reyes J, Beiderman R, Sindhi, Mazariegos GV. Causes of late mortality beyond one year following pediatric liver transplant under tacrolimus. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #392.

  126. Pettiford B, Cacciarelli TV, Eghtesad B, AB Jain, Planinsic R, Reyes J, Fung JJ, Kormos RL. Simultaneous heart-liver transplantation: A worthwhile effort? XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #622.

  127. Eghtesad B, Daly I, Broznick BA, Geller DA, Cacciarelli TV, Fontes PA, Bonham CA, Dodson SF, AB Jain, Marsh JW, Fung JJ. Utilization of livers from non-heartbeating donors (NHBD): A single center experience. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #1664.

  128. AB Jain, Scantlebury V, Shapiro R, Eghtesad B, Pokharna R, Reyes J, Potdar J, Flohr J, Fung JJ. Pregnancy post liver, kidney and kidney + pancreas transplant under tacrolimus. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #2106.

  129. Zak M, Bond GJ, AB Jain, Murase N, Canady J, Mazariegos G, Reyes J, Abu-Elmagd KM. De novo malignancy among intestinal allograft recipients. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #2710.

  130. Basu A, AB Jain, Shapiro R, Scantlebury V, Potdar S, Jordan ML, Corry RJ. Safety and efficacy of low-dose thymoglobulin (rabbit anti-thymocyte globulin) for steroid-resistant rejection after pancreas transplantation under tacrolimus. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #2876.

  131. Scantlebury V, Shapiro R, Jordan M, Corry R, Abu-Elmagd KM, Reyes J, Vivas C, AB Jain, Potdar S, Fung JJ, Starzl TE. The use of preconditioning and postoperative monotherapy in African-American kidney and other organ recipients. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #3334.

  132. Basu A, AB Jain, Horn E, Garrido V, Potdar S, Scantlebury V, Jordan ML, Shaprio R. Efficacy of low dose thymoglobulin versus OKT3 in steroid-resistant rejections (SRR) after kidney transplantation under tacrolimus. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #3340.

  133. Shapiro R, Scantlebury VP, Jordan ML, Corry RJ, Potdar S, AB Jain, Vivas C, Randhawa P, Basu A, Smetanka C, Gray E, Murase N, Woodward J, Zeevi A, Demetris AJ, Fung JJ, Starzl TE. Kidney transplantation under tolerogenic regimen of thymoglobulin preconditioning and post-transplant tacrolimus monotherapy. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4):Suppl, Abstract #3343.

  134. AB Jain, Nalesnik MA, Reyes J, Pokharna R, Mazariegos GV, Cacciarelli TV, Marsch JW, Fontes PA, De Vera MA, Marcos A, Eghtesad B, Fung JJ. Lymphoproliferative Disorder (PTLD) In Children and Adults under Tacrolimus: 2, 000 consecutive Liver Transplant Patients: 12 Years Experience. Post-Transplant. 9th Meeting of International Liver Transplant. May 30 – June 4, 2003, Barcelona Spain. Liver Transplantation June 2003, Vol 9 No 6. Abstract#88, pp. C-22.

  135. AB Jain, Venkataramanan R, Gadomski M, Eghtesad B, Marcos A, Fung JJ. Use of mycophenolate mofetil (MMF) for tacrolimus-related, chronic nephrotoxicity in post liver transplant (LTX) patients: long-term prospective trial with minimum six years follow up. 9th Meeting of International Liver Transplant. May 30 – June 4, 2003, Barcelona Spain. Liver Transplantation. June 2003 Vol 9 No 6. Abstract#169, pp. C-43.

  136. AB Jain, VenkataramananR, Eghtesad B, Marcos A , Ragni M, Shapiro R, Rafail A, Fung JJ. Profound drug interaction with a combination of two protease inhibitors (PI: ritonavir and lopinavir: kaletra) and tacrolimus in post-liver transplant (LTX) patients with HIV infection. 9th Meeting of International Liver Transplant. May 30 – June 4, 2003, Barcelona Spain. Pittsburgh, PA, USA. Liver Transplantation. June 2003 Vol 9 No 6. Abstract#323, pp. C-81.

  137. Potdar S, Martin JA, Malek SK, Thai N, Tublin M, Sharma S, Basu A, AB Jain, Shapiro S, Fung JJ, Percutaneous ultrasound guided pancreas allograft biopsy-single center experience. American Transplant Congress, May 30-June 4, 2003, Washington DC, Abstract#397 American Journal of Transplantation. Suppl, 5 (3); pp. 253.

  138. Potdar S, Shapiro R, Thai N, AB Jain, Randhawa P, Demetris AJ, Basu A, Marcos A, Fung JJ, Successful Reversal of refractory Acute Rejection with Campath 1H in Pancreas Transplant Recipients. American Transplant Congress, May 30-June, 2003, Washington DC, Abstract#670, American Journal of Transplantation. Suppl, 5. (3); pp. 324.

  139. Kwak EJ, AB Jain, Ragni MV, Fung JJ, Kusne S. Infectious complications in recipients of liver transplantation co-infected with human immunodeficiency virus (HIV)American. American Transplant Congress, May 30-June, 2003, Washington DC, Abstract#1100, American Journal of Transplantation. Suppl.5. (3);pp. 433.

  140. Eghtesad B, Broznick B, Kusum P, Sayeed M, Thomas C, AB Jain, De Vera ME, Fontes PA, Gayowski T, Marsh W, Marcos A, Fung J. Surgery, Comparison of histidine- tryptophanketoglutarate (HTK) solution versus university of Wisconsin (UW) solution for organ preservation in liver transplantation. American Transplant Congress, May 30-June, 2003, Washington DC, Abstract#1172, American Journal of Transplantation. Suppl. 5. (3);pp. 452.

  141. Bozorgzadeh A, AB Jain, Daller J, Ryan C, Sundrum U, Lansing K, Kaufmann D, Ornt D, Zand M, Betts R, Orloff M. Impact of hepatitis C viral (HCV) infection in primary cadaveric liver allograft v/s primarily living liver allograft in 100 consecutive liver transplant patients. 54th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, October 24-28, 2003. Abstract#770, Suppl 1, Hepatology. 34(4);pp.532A

  142. AB Jain 1*, Mark Orloff 1, Kerrie Lansing 1, Randeep Kashyap 1, Mark Kelley 1, Robert Betts 1, Marilyn Menegus 1 and Adel Bozorgzadeh 1. 1 Surgery, Strong Memorial Hospital, Rochester, NY, United States. High rate of symptomatic cytomegaloviral (CMV) infection with valgan (ganciclovir hydrochloride) prophylaxis in post liver transplant recipients. American Journal of Transplantation 2004, Supp 8: Vol 4, P 569, Abstract #1499

  143. AB Jain 1*, Raman Venkataramanan 3, Bijan Eghtesad 2, Randeep kashyap 1, Barbara yelochan 2, Amadeo Marcos 2 and John Fung. Value of Ribavirin concentration measurement in plasma/blood in post liver transplant patients with hepatitis C virus (HCV) infection. American Journal of Transplantation 2004, Supp 8: Vol 4, P 356, Abstract #727.

  144. AB Jain1,2, J Reyesf1, A.Marcos1, R. Kashyap 2 G. Mazariegos1.Bijan Eghtesad1, W. Marsh1, P. Fonte1s, M. DeVera1, J Fung1 Surgical/Non Surgical, Immunological/Non Immunological, Early and Late complications after primary Liver Transplantation and its impact on graft and patient survival in adults and children. An analysis of 1000 consecutive patients with 9-12 years follow-up. American Journal of Transplantation 2004, Supp 8: Vol 4, P359, Abstract #739.

  145. Ashokkumar Jain, Mark Orloff, Randeep Kashyap, Kerrie Lansing, Roberts Betts, Merelyn Menegus, Charlotte Ryan, Peter Abt, Adel Bozorgzadeh Does Valganciclovir Hydrochloride (Valcyte TM) Provide Effective Prophylaxis against Cytomegalovirus (CMV) Infection in Liver Transplant Recepients? Transplant proc Supplement 2004; 36 (10S) 627S

  146. Randeep Kashyap, Ashok Jain, Renu Pokharna, Kareem Abu-Elmagd, Ron Shapiro, Velma Scantlebury, Bijan Eghtesad, Paulo Fontes, Mary Gadornski, Amadeo Marcos, John Fung Impact of Cytomegalovirus (CMV) Hepatitis in Adult Post Transplant Allograft under Tacrolimus Transplant proc Supplement 2004; 36 (10S) 627S

  147. A Jain, M Orloff, R Kashyap, B Kari, A Bozorgzadeh. Use of Intravenous Mycophenolate Mofetil and delated us of Tacrolimus in Deceased Donor Liver Transplantation to preserve Renal function Transplant proc Supplement 2004; 36 (10S) 629S

  148. G Costa, Ashokkumar Jain, Amadio Marcos, Jorge Reyes, George Mazariegos, R Kashyap, John J Fung Incidence of Bile Duct complications following Primary Liver Transplantation in Adults and Children: 1000 consecutive patients Transplant proc Supplement 2004; 36 (10S) 633S

  149. Michael E de Vera, Bijan Eghtesad, Ashokkumar Jain, John J Fung, Progression and treatment of recurrent Hepatitis C after Liver Transplantation in patients co-infected with HIV. Hepatology 38(4):161A 2003

  150. Adel Bozorgzadeh, Kerrie Lansing, Duraid Younan, Randeep Kashyap, Peter Abt, Ashok Jain, Mark Orloff. Survival & Outcomes in Hepatitis C (HCV) infected liver transplant (LTx) recipients with hepatocellular carcinoma (HCC). 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA. Liver Transplantation 2005 11(7); C-3; Abstract #9

  151. Duraid Younan, Randeep Kashyap, Peter Abt, Kerrie Lansing, Ashokkumar Jain, Parvez Mantry, Mark Orloff, Adel Bozorgzadeh. Hepatic artery stenosis in orthotopic liver transplantation (LTx): single centre experience in a series of 527 patients. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA. Liver Transplantation 2005 11(7); C-13; Abstract #52

  152. Ashokkumar B Jain, Mark Orloff, Peter Abt, Ravi R Mohanka, Randeep Kashyap, Adel Bozorgzadeh. University of Wisconsin (UW) versus Histidine-Tryptophan-Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-15; Abstract #60

  153. Peter Abt, Adel Bozorgzadeh, Duraid Younan, Randeep Kashyap, Kerrie Lansing, Ashok Jain, David Kauffman, Martin Zand, Mark Orloff. An association between healthcare utilization and outcomes in the MELD era. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-22; Abstract #87

  154. Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Ashokkumar Jain, Kerrie Lansing, Duraid Younan, Parvez Mantry, Mark Orloff. Optimal use of extended criteria organds in the MELD era. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-23; Abstract #89

  155. Adel Bozorgzadeh, Kerrie Lansing, Duraid Younan, Peter Abt, Randeep Kashyap, Robert Betts, Ashok Jain, Mark Orloff. Risk factors and inplicaitons of Vanclmycin resistant enterococcus (VRE) in liver transplant recipients. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-31; Abstract #123

  156. Ashokkumar B Jain, Marilyn Menegus, Ravi R Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzdeh, Post liver transplant (LTx) hepatitis C viral (HCV) antibody titre in relation to hepatitis C viral load, hepatic injury and response to anti-HCV treatment – preliminary results. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-41; Abstract #163

  157. Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Kerrie Lansing, Duraid Younan, Ashokkumar Jain, Parvez Mantry, Mark Orloff. An association of pre-transplant HCV associated cryoglobulinemia (CRG) with post-liver transplant survival outcomes. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-48; Abstract #189

  158. Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Kerrie Lansing, Duraid Younan, Ashokkumar Jain, Parvez Mantry, Mark Orloff. Outcome of hepatitis C patients co-infected with cytomegalovirus (CMV) infection post-liver transplant (LTx). 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-48; Abstract #190

  159. Randeep Kashyap, Duraid Younan, Kerrie Lansing, Peter Abt, Ashokkumar Jain, Mark Orloff, Adel Bozorgzadeh. Donor/Recipient cytomegalovirus (CMV) status and its influence on hepatic artery thrombosis (HAT) post-liver transplantation (LTx). 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-49; Abstract #193

  160. A B Jain, M Orloff, R Mohanka, R Kashyap, M Kelly, B Kari, P Abt, A Bozorgzadeh. Intravenous mycophenolate mofetil and delayed use of tacrolimus in deceased and live donor liver transplantation for preservation of renal function. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-56; Abstract #222

  161. Randeep Kashyap, Peter Abt, Duraid Younan, Kerrie Lansing, Ashokkumar Jain, Mark Orloff, Adel Bozorgzadeh. Liver transplantation from non-heart beating donor (NHBD) – a single centre experience. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-61; Abstract #243

  162. Adel Bozorgzadeh, Peter Abt, Kerrie Lansing, Randeep Kashyap, Duraid Younan, Ashokkumar Jain, Parvez Mantry, Mark Orloff. Outcome of late stage hepatocellular carcinoma (HCC) those outside Milan/University of California, San Francisco (UCSF) criteria: results of a single centre study. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA Liver Transplantation 2005 11(7); C-64; Abstract #253

  163. Ashokkumar B Jain, Mark Orloff, Peter Abt, Ravi R Mohanka, Randeep Kashyap, Jackie Cullen, Adel Bozorgzadeh. Intra-operative biochemical changes in live donor liver transplantation at the end of parencymal division. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los angeles, CA, USA. Liver Transplantation 2005 11(7); C-66; Abstract #264

  164. Ashok Jain, Ravi Mohanka, Mark Orloff, Peter Abt, Randeep Kashyap, Parvez Mantry, Jackie Cullen, Kerrie Lansing, Adel Bozorgzadeh. Intraoperative biochemical changes in live donor liver transplantation at the end of parenchymal division and its post-operative impact. 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland Transplant International 2005 Oct; 18(Suppl 1): 245 Abstract #PO-885

  165. Ashok Jain, Mark Orloff, Ravi Mohanka, Randeep Kashyap, Mark Kelley, Kari Burlee, Adel Bozorgzadeh. Intravenous mycophenolate mofetil and delayed use of tacrolimus in deceased and live donor liver transplantation for preservation of renal function. 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland Transplant International 2005 Oct; 18(Suppl 1): 117 Abstract #PO-279

  166. Ashok Jain,Marilyn Menegus, Ravi Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh. HCV antibody quantitative levels in post-liver transplant patients: do they have any relevance in clinical practice? 12th Congress of the European Societyfor Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva,Switzerland Transplant International 2005 Oct; 18(Suppl 1): 213 Abstract #PO-735

  167. Ashok Jain, Mark Orloff, Peter Abt, Ravi Mohanka, Randeep Kashyap, Jackie Cullen, Adel Bozorgzadeh. University of Wisconsin (UW) versus Histidine – Tryptophan – Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland Transplant International 2005 Oct; 18(Suppl 1): 245 Abstract #PO-886

  168. Ashok Jain, Charlotte Ryan, Ravi Mohanka, Mark Orloff, Peter Abt, Joan Romano, Leah Bryan, Pam Batzold, Adel Bozorgzadeh. Use of complement C4d stain to distinguish between acute cellular rejection and recurrent hepatitis C in post liver transplant liver biopsy. 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 11 – 15, 2005. San Francisco, California, USA Hepatology 2005 Oct; 42 (4 Suppl 1): 484A Abstract #732

  169. Ashok Jain, Ravi Mohanka, Tai Kwong, Jamie Nelson, Cynthia Mack, Mark Orloff, Peter Abt, Adel Bozorgzadeh. Kinetics observation of IV Mycophenolate mofetil (MMF) and oral MMF in live donor and diseased donor liver transplantation (LTx). 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 11 – 15, 2005. San Francisco, California, USA. Hepatology 2005 Oct; 42 (4 Suppl 1): 329A Abstract #338

  170. Mark Nickels, Ashokkumar Jain, Ravi Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh. Non-alcoholic Substance Abuse in Liver Transplant Patients and its Impact on Survival Outcome. 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 11 – 15, 2005. San Francisco, California, USA. Hepatology 2005 Oct; 42 (4 Suppl 1): 335A Abstract #352